Key figures
Data as of Jun 2026 · Pills compare vs Mar 2026Revenue, margins & ratios from SEC filings; market cap & ARR multiple from market data. Market cap & ARR multiple use the close of 2 Oct 2026; their pills compare vs the Jun 2026 quarter-end (6.0x).
Valuation by quarter
Calculated valuation
FRAMEWORK EST.Strategy recommendations
Levers ranked by valuation impactEstimated likelihood that general-purpose AI replaces this product.
Open AI Risk Calculator →Why this rating
From the AI Risk Calculator modelStructural moats (regulation, integration depth, or proprietary data) make AI-only replacement unlikely in the near term.
Company overview
Doximity is a professional network for doctors. Think LinkedIn, but built only for physicians and other clinicians. Jeff Tangney founded the company in 2010 in San Francisco. It went public in 2021.
Most United States doctors have joined. That is a remarkable fact and the source of the company power. Physicians use Doximity to connect with colleagues, read medical news, send secure messages, and even run telehealth visits with patients.
The business makes money in a clever way. Pharmaceutical companies and hospitals pay to reach this hard to reach audience. A drug maker can share information about a new treatment with the right specialists. A hospital can recruit doctors for open roles. Because the network is so complete, that access is valuable.
Imagine a cardiologist between patients. She checks Doximity for the latest study on a heart drug, messages a colleague about a tricky case, and dials into a quick video visit, all in one app. That daily habit is what advertisers pay for.
Doximity stands out for a rare trait among newer software firms. It is highly profitable. Revenue runs above $550 million a year with fat margins and strong cash flow. The company grows by deepening how much doctors rely on it. Own the audience, and the rest follows.
Entity information
SaaS KPIs
Reported in at least 3 quartersAdjusted EBITDA Margin
Free Cash Flow
Adjusted EBITDA
Net Revenue Retention
Non-GAAP Net Income Margin
Non-GAAP Net Income
Guidance
Q1 FY2027 earnings report →Management outlook
Quarterly financials
Left axis in $ (Revenue, Gross profit, Net income, S&M); right axis for ratios (Rule of 40, Magic number). Click a legend item to toggle it.